Etravirine as a Switching Option for Patients with HIV RNA Suppression: A Review of Recent Trials

First Page		Document Content
Carbamates Organofluorides Protease inhibitors Gilead Sciences Etravirine Efavirenz Antiretroviral drug Darunavir Nevirapine Chemistry Organic chemistry Non-nucleoside reverse transcriptase inhibitors		Etravirine as a Switching Option for Patients with HIV RNA Suppression: A Review of Recent Trials Add to Reading List Source URL: www.ncbi.nlm.nih.gov Download Document from Source Website File Size: 535,32 KB Share Document on Facebook

	Impact of Concomitant Antiretrovirals, and CYP2C9 and CYP2C19 Polymorphisms on the Pharmacokinetics of Etravirine 1 2 DocID: 1omXF - View Document
	Microsoft Word - jccintel11014 DocID: 15FpR - View Document
	SMC briefing note Scottish Medicines Consortium advice to NHSScotland Monthly briefings are produced in order to help members of DocID: XwC6 - View Document
	AIDS InfoNet www.aidsinfonet.org Fact Sheet Number 434 DocID: RQqA - View Document
	AIDS InfoNet www.aidsinfonet.org Fact Sheet Number 435 DocID: RKHR - View Document